News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306,818 Results
Type
Article (28791)
Company Profile (75)
Press Release (277949)
Multimedia
Podcasts (52)
Webinars (9)
Section
Business (77588)
Career Advice (877)
Deals (11088)
Drug Delivery (48)
Drug Development (46307)
Employer Resources (78)
FDA (7016)
Job Trends (6972)
News (142448)
Policy (14480)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (2203)
Accelerated approval (12)
Adcomms (17)
Allergies (61)
Alliances (24364)
ALS (92)
Alzheimer's disease (997)
Antibody-drug conjugate (ADC) (156)
Approvals (7195)
Artificial intelligence (308)
Autoimmune disease (80)
Automation (20)
Bankruptcy (83)
Best Places to Work (6097)
BIOSECURE Act (16)
Biosimilars (77)
Biotechnology (58)
Bladder cancer (78)
Brain cancer (33)
Breast cancer (405)
Cancer (2786)
Cardiovascular disease (161)
Career advice (734)
Career pathing (11)
CAR-T (163)
CDC (57)
Cell therapy (413)
Cervical cancer (27)
Clinical research (37542)
Collaboration (950)
Compensation (138)
Complete response letters (20)
COVID-19 (2619)
CRISPR (78)
C-suite (382)
Cystic fibrosis (91)
Data (3613)
Denatured (10)
Depression (44)
Diabetes (210)
Diagnostics (2847)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (20)
Drug discovery (158)
Drug pricing (78)
Drug shortages (7)
Duchenne muscular dystrophy (97)
Earnings (24562)
Editorial (33)
Employer branding (9)
Employer resources (70)
Events (41649)
Executive appointments (429)
FDA (8615)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (15)
Funding (869)
Gene editing (150)
Generative AI (30)
Gene therapy (358)
GLP-1 (375)
Government (3269)
Grass and pollen (3)
Guidances (163)
Healthcare (8745)
HIV (38)
Huntington's disease (17)
IgA nephropathy (36)
Immunology and inflammation (113)
Immuno-oncology (31)
Indications (58)
Infectious disease (2874)
Inflammatory bowel disease (119)
Inflation Reduction Act (7)
Influenza (119)
Intellectual property (96)
Interviews (117)
IPO (5340)
IRA (26)
Job creations (1163)
Job search strategy (644)
JPM (19)
Kidney cancer (10)
Labor market (35)
Layoffs (203)
Leadership (9)
Legal (2187)
Liver cancer (38)
Longevity (8)
Lung cancer (348)
Lymphoma (198)
Machine learning (20)
Management (29)
Manufacturing (342)
MASH (66)
Medical device (4345)
Medtech (4355)
Mergers & acquisitions (6211)
Metabolic disorders (504)
Multiple sclerosis (103)
NASH (8)
Neurodegenerative disease (158)
Neuropsychiatric disorders (29)
Neuroscience (1607)
Neurotech (1)
NextGen: Class of 2026 (2706)
Non-profit (2614)
Now hiring (15)
Obesity (208)
Opinion (133)
Ovarian cancer (115)
Pain (74)
Pancreatic cancer (117)
Parkinson's disease (144)
Partnered (15)
Patents (192)
Patient recruitment (262)
Peanut (23)
People (26387)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase 1 (14112)
Phase 2 (16103)
Phase 3 (11113)
Pipeline (2717)
Policy (194)
Postmarket research (1314)
Preclinical (6459)
Press Release (42)
Prostate cancer (139)
Psychedelics (29)
Radiopharmaceuticals (125)
Rare diseases (443)
Real estate (2181)
Recruiting (33)
Regulatory (11498)
Reports (21)
Research institute (2218)
Resumes & cover letters (165)
Rett syndrome (12)
RNA editing (12)
RSV (80)
Schizophrenia (61)
Series A (132)
Series B (104)
Service/supplier (1)
Sickle cell disease (64)
Special edition (4)
Spinal muscular atrophy (83)
Sponsored (19)
Startups (1875)
Stomach cancer (5)
Supply chain (47)
Tariffs (31)
The Weekly (41)
Vaccines (1165)
Venture capital (38)
Weight loss (99)
Women's health (33)
Worklife (5)
Date
Today (12)
Last 7 days (223)
Last 30 days (933)
Last 365 days (13672)
2026 (1546)
2025 (13791)
2024 (16550)
2023 (19033)
2022 (25506)
2021 (27477)
2020 (24790)
2019 (19907)
2018 (15153)
2017 (14213)
2016 (13874)
2015 (16237)
2014 (12125)
2013 (10161)
2012 (10566)
2011 (11082)
2010 (9716)
Location
Africa (454)
Alabama (66)
Alaska (5)
Arizona (125)
Arkansas (6)
Asia (19994)
Australia (3980)
California (4755)
Canada (1299)
China (556)
Colorado (185)
Connecticut (243)
Delaware (184)
Europe (43534)
Florida (787)
Georgia (172)
Hawaii (2)
Idaho (22)
Illinois (327)
India (38)
Indiana (200)
Iowa (12)
Japan (241)
Kansas (40)
Kentucky (22)
Louisiana (14)
Maine (13)
Maryland (823)
Massachusetts (3700)
Michigan (94)
Minnesota (217)
Mississippi (1)
Missouri (64)
Montana (16)
Nebraska (13)
Nevada (28)
New Hampshire (24)
New Jersey (1629)
New Mexico (12)
New York (1487)
North Carolina (638)
North Dakota (9)
Northern California (2362)
Ohio (143)
Oklahoma (12)
Oregon (12)
Pennsylvania (1005)
Puerto Rico (7)
Rhode Island (25)
South America (490)
South Carolina (18)
Southern California (1819)
Tennessee (70)
Texas (790)
United States (18178)
Utah (111)
Vermont (1)
Virginia (118)
Washington D.C. (50)
Washington State (492)
West Virginia (3)
Wisconsin (54)
306,818 Results for "duke human vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions
February 10, 2026
·
5 min read
Press Releases
Centivax Initiates Phase 1 First-in-Human Clinical Trial of Universal Flu Vaccine
February 12, 2026
·
5 min read
Press Releases
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
December 5, 2025
·
4 min read
influenza
Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine
The money replaces a small portion of a contract Moderna lost when the Department of Health and Human Services canceled $760 million in backing to develop the vaccine, called mRNA-1018.
December 18, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)
December 15, 2025
·
5 min read
Press Releases
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
October 16, 2025
·
3 min read
Press Releases
Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine
November 7, 2025
·
10 min read
Press Releases
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
January 1, 2026
·
7 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
January 28, 2026
·
5 min read
Mergers & acquisitions
The 7 Most Impactful M&A Deals of 2025
These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down after another failed acquisition or, in the case of Pfizer and Novo, two heavyweights duking it out over a hot obesity biotech.
December 17, 2025
·
7 min read
·
Dan Samorodnitsky
1 of 30,682
Next
